{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:04:44Z","timestamp":1789236284509,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jvoice.2021.02.018","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T04:58:49Z","timestamp":1615093129000},"page":"433-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mu-Opioid Receptor Expression in Laryngeal Cancer"],"prefix":"10.1016","volume":"37","author":[{"given":"Yonatan","family":"Lahav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Huszar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Cata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Shoffel-Havakuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2021.02.018_bib0001","unstructured":"Research Data (1975-2016), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Stat Facts: Laryngeal Cancer. Surveillance, epidemiology, and end results (SEER) program. Available at: www.seer.cancer.gov. Accessed February 26, 2020."},{"key":"10.1016\/j.jvoice.2021.02.018_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000446117","article-title":"Global epidemiology of head and neck cancers: a continuing challenge","volume":"91","author":"Gupta","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0003","series-title":"Head and Neck Cancer (Version 1.2020)","year":"2020"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0004","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archotol.134.4.370","article-title":"Five-year survival rates and time trends of laryngeal cancer in the US population","volume":"134","author":"Cosetti","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000276258","article-title":"Supraglottic versus glottic laryngeal cancer: epidemiological and pathological aspects","volume":"54","author":"Silvestri","year":"1992","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/019459989210700411","article-title":"Risk factors of cancer of the larynx: results of the Heidelberg case-control study","volume":"107","author":"Maier","year":"1992","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0007","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/CEJ.0b013e3282b6fd40","article-title":"Alcohol and laryngeal cancer: an update","volume":"17","author":"La Vecchia","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0008","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/1097-0142(19920501)69:9<2244::AID-CNCR2820690906>3.0.CO;2-O","article-title":"Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer","volume":"69","author":"Muscat","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0009","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/coa.12990","article-title":"Intravenous opioid drug abuse as an independent risk factor for supraglottic squamous cell carcinoma\u2014a case-control study","volume":"43","author":"Shoffel-Havakuk","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0010","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/00005537-200311000-00016","article-title":"Opium and risk of laryngeal cancer","volume":"113","author":"Mousavi","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0011","first-page":"307","article-title":"Radiotherapy of carcinoma of the Larynx","volume":"10","author":"Khoo","year":"1981","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0012","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2011.05.028","article-title":"Methadone maintenance and cancer risk: an Israeli case registry study","volume":"119","author":"Grinshpoon","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0013","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10620-007-9897-y","article-title":"Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon","volume":"53","author":"Nylund","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jvoice.2021.02.018_bib0014","doi-asserted-by":"crossref","first-page":"i103","DOI":"10.1093\/bja\/aeu165","article-title":"Increased mu-opioid receptor expression in metastatic lung cancer","volume":"113","author":"Singleton","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/dote.12165","article-title":"Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma","volume":"28","author":"Zhang","year":"2015","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0016","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/ALN.0b013e31824babe2","article-title":"Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis","volume":"116","author":"Lennon","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0017","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1002\/cncr.28345","article-title":"Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer","volume":"119","author":"Zylla","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0018","first-page":"2","article-title":"MOR1 expression in gastric cancer: a biomarker associated with poor outcome","volume":"8","author":"Yao Y","year":"2012","journal-title":"CTS journal"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0019","series-title":"Census Data","year":"2008"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/0300985813485099","article-title":"Principles for valid histopathologic scoring in research","volume":"50","author":"Gibson-Corley K","year":"2013","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00726-011-1163-0","article-title":"Role of the mu-opioid receptor in opioid modulation of immune function","volume":"45","author":"Ninkovi\u0107","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0022","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/00016489109135003","article-title":"Microvascular structure of the larynx. A scanning electron microscopic study of microcorrosion casts","volume":"486","author":"Nakai","year":"1991","journal-title":"Acta Otolaryngol Suppl"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0023","series-title":"Normal Anatomy, Histology and Heterotopia of the Larynx. Atlas of Ear, Nose and Throat Pathology, Volume 16 of the series Current Histopathology","first-page":"82","author":"Michaels","year":"1990"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0024","first-page":"3","article-title":"Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs","volume":"9","author":"Takahama","year":"2007","journal-title":"Cough"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0025","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00405-010-1249-4","article-title":"Differential beta-catenin expression between glottic and supraglottic laryngeal carcinoma","volume":"267","author":"Goulioumis","year":"2010","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0026","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1017\/S0022215106002726","article-title":"The immunohistochemical expression of p21WAF1\/Cip1 and proliferating cell nuclear antigen in laryngeal squamous cell carcinomas","volume":"120","author":"Li","year":"2006","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00405-007-0441-7","article-title":"Glottic versus supraglottic tumors: differential molecular profile","volume":"265","author":"Kourelis","year":"2008","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0028","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0959-8049(02)00115-6","article-title":"Supraglottic and glottic carcinomas: clinically and biologically distinct entities?","volume":"38","author":"Hirvikoski","year":"2002","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jvoice.2021.02.018_bib0029","first-page":"S153","article-title":"75 years of opioid research: the exciting but vain quest for the Holy Grail","volume":"147","author":"Corbett","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0030","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/lary.27791","article-title":"Chronic opioid use in patients undergoing treatment for oropharyngeal cancer","volume":"129","author":"Silver","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2021.02.018_bib0031","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamaoto.2017.0582","article-title":"Chronic opioid use following surgery for oral cavity cancer","volume":"143","author":"Pang","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:42:20Z","timestamp":1760211740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199721000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0892199721000886"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.02.018","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mu-Opioid Receptor Expression in Laryngeal Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}